InvestorsHub Logo
Followers 93
Posts 8868
Boards Moderated 0
Alias Born 05/06/2014

Re: None

Monday, 07/26/2021 12:39:37 PM

Monday, July 26, 2021 12:39:37 PM

Post# of 78063
Great news in a great sector and great share structure. Gotta love this part:

He was named one of the world's top 3% scientists four years in a row. The National Cancer Center selected Dr. Lee as "The Outstanding Scientist of the Year." He has published over 200 research papers, with approximately 90 through the Science Citation Index (SCI).

His research includes CBD research and SCI international cancer research papers. He developed a cancer drug using natural products, small molecular compounds and antibodies. Dr. Lee has fifteen registered patents.

Dr. Lee has brought to Kaiyon Biotech Inc. a consortium of prestigious scientists and researchers that share in his mission to discover, formulate, and license psilocybin and CBD medicines to be used in the treatment of dementia, schizophrenia, manic depression, sleep disorder, PTSD, cancer and autism.

According to Dr. Lee, the scientists hired at Kaiyon Biotech are each strategic for their contribution to research, and there is KFDA approval for studying psilocybin and CBD.

Dr. DaeHee Lee received a Master of Science and Doctorate of Philosophy in biotechnology and food science from Korea University at Seoul.